.jpg)
.png)
All
This issue sponsored by the Southeast Lipid Association Featuring: "An Update on Statin Safety with an Emphasis on Differences” and “Managing the Statin-Intolerant Patient: Low-Dose/Low-Frequency Treatment Regimens"
I am pleased to present to the National Lipid Association the Spring 2013 issue of the Lipid Spin. The Pacific Lipid Association serves the states of Washington, Oregon, California, Idaho, Montana, Nevada, Utah, Alaska, and Hawaii. The theme of this Spring issue is "Roles of Common... more
.jlbox { background-color: #e31e27; padding: 15px; width:50%; text-align: center; margin: auto; } .jlcell { margin: auto; text-align: center; } .jlcell p { color:#FFFFFE; padding: 0 10px; } Visit the Journal Website Click here to be... more
The National Committee for Quality Assurance (NCQA) has proposed retiring the use of LDL-C treatment targets in response to the new ACC/AHA Task Force on Practice Guidelines. The NCQA has stated that no studies focus on treatment or titration to a specific LDL-C goal in adults with clinical... more
This issue is sponsored by the Northeast Lipid Association. Featuring: "Evaluation of Women for the Primary Prevention of Atherosclerotic Cardiovascular Disease" "Current Understanding of the Contribution of Lipoprotein(a) to Atherosclerotic CardiovascularDisease Risk in Women" "Conventional... more
Recommendations & Statements The National Lipid Association ("NLA") strives to champion issues of Clinical Lipidology for its members and for practitioners in the United States and internationally. In this role, the NLA has authored and endorsed various expert... more
.field-name-field-publish-date, li.statistics_counter.first.last { display:none; } .checkout-btn{display:none} .page-header{display:none}
According to the 2011 National Diabetes fact sheet, 25.8 million adults and children in the United States (8.3%) have diabetes and 79 million have pre-diabetes. In 2010 alone, 1.9 million new cases of diabetes were diagnosed. In 2007, the total cost of diagnosed diabetes was $174 billion and... more
The National Lipid Association (NLA) welcomes the results of the REVEAL trial which demonstrated that reductions in cholesterol levels with anacetrapib were associated with a reduction in cardiovascular events. Specifically, cholesterol drug anacetrapib produced reductions in low density... more
Vitamin D: Merging Research into a Clinical Lipid Practice Case Studies from the files of Thomas Dayspring, MD